Vasily Fedorin

Verksamhetschef på

4BIO Ventures Management Ltd.

Distribution Services

Consumer Services

Finance

Profil

Vasily Fedorin is currently the Chief Operating Officer at 4BIO Ventures Management Ltd. He previously worked as a Marketing Manager at MS WESTFALIA GmbH from 2009 to 2010.
Dr. Fedorin holds a doctorate degree from Lomonosov Moscow State University Business School, which was conferred in 2008.

Aktiva positioner av Vasily Fedorin

Företag	Position	Start
4BIO Ventures Management Ltd. 4BIO Ventures Management Ltd. Investment ManagersFinance 4bio Ventures invest in companies located in the United Kingdom. The firm targets the companies operating in the fields of gene therapy, cell theray, RNA based therapy, targeted therapies and microbiome. They provide financing for early stage capital requirements.	Verksamhetschef	2022-03-01

Alla aktiva positioner av Vasily Fedorin

Tidigare kända positioner av Vasily Fedorin

Företag	Position	Slut
MS WESTFALIA GmbH MS WESTFALIA GmbH Medical DistributorsDistribution Services Distributes medical equipment	Privat kapitalinvesterare	2010-02-01

Se detaljerna i Vasily Fedorins erfarenhet

Vasily Fedorins utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Vasily Fedorins erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	3
MS WESTFALIA GmbH MS WESTFALIA GmbH Medical DistributorsDistribution Services Distributes medical equipment	Distribution Services
Lomonosov Moscow State University Business School Lomonosov Moscow State University Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
4BIO Ventures Management Ltd. 4BIO Ventures Management Ltd. Investment ManagersFinance 4bio Ventures invest in companies located in the United Kingdom. The firm targets the companies operating in the fields of gene therapy, cell theray, RNA based therapy, targeted therapies and microbiome. They provide financing for early stage capital requirements.	Finance